It’s been a busy week in the life sciences! Discover the latest developments below in this edition of Week in […] ...

What’s been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news from ...

It’s not just genomics; this year’s Festival hosts the widest range of topics yet, including multi-omics, single-cell, spatial, AI in drug discovery, advanced therapies, proteogenomics & translational ...

What’s been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news from the last seven days. New AI model detects disease risk years in advance.

Written by Arpita Kulkarni (Director of the Functional Genomics and Bioinformatics Core at HMS/BIDMC). Across the life sciences, a quiet anxiety is growing: what is the role of the experimental ...

Next generation sequencing has become a fundamental approach in many aspects of life science research and impressive innovation continues to push the boundaries even further. We are pleased to ...

‘The $100 Genome: Where’s the Limit?’ was originally published in April 2024. Few advancements in the life sciences field have been as transformative as the ability to sequence the human genome. Since ...

This feature was written using content from out recenty published Proteomics Playbook, which you can download for FREE here. The sequence of a protein is critical as it largely dictates the protein’s ...

Analysis of proteins is not simple. Unlike DNA, there is incredible diversity in the concentration and variety of proteins created by a cell at any given moment. In our Proteomics Playbook we outline ...

The microbiome is made of up trillions of microorganisms, each playing a crucial role – good or bad – in our health and wellbeing. Varying from one organ to another, and between every individual, the ...

All our webinars are free to attend. Join us for content focusing on: single cell, liquid biopsy, cancer genomics, multi-omics, microbiome and more!

Next generation sequencing (NGS) is a powerful tool for uncovering a patient’s inherited susceptibility to cancer, paving the way for more effective prevention strategies. However, hereditary cancer ...